STAT1 and cancer: However, accumulating evidence also associates elevated STAT1 and phosphorylated STAT1 (p-STAT1) levels with unfavorable clinical outcomes in diverse cancer types 27, 28, potentially due to STAT1-driven expression of proinflammatory cytokines and chemokines 29.